Companies: 10,795·Total market cap: $144.5T
Canopy Growth Corporation

Canopy Growth Corporation

CGCNASDAQHealthcare● Active
$1.02
$-0.01(-0.97%)
Market Cap$434352720
P/E Ratio
52W High$2.38
52W Low$0.844

Canopy Growth Corporation (CGC) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · CGC · as of Sep 30, 2025

Ownership Breakdown

Institutions 7.55%
Insiders 0.38%
Public 92.07%

232

Institutional Holders

▲ 12 vs Q2

$46.95M

Total Inst. Value

▲ $25.99M vs Q2

425.84M

Shares Outstanding

freeFloat 99.62%

32.15M

13F Shares Held

▲ 14.98M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

CGC largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

TOROSO INVESTMENTS, LLC

medicinal chemicals & botanical products

4.85M2.58%

2.58%

$7.09BNov 14, 2025 179.2K

SUSQUEHANNA INTERNATIONAL GROUP, LLP

medicinal chemicals & botanical products

3.88M2.06%

2.06%

$5.66BNov 14, 2025 2.77M

CITADEL ADVISORS LLC

medicinal chemicals & botanical products

3.64M1.93%

1.93%

$5.32BNov 14, 2025 2.69M

MILLENNIUM MANAGEMENT LLC

medicinal chemicals & botanical products

3.14M1.67%

1.67%

$4.58BNov 14, 2025 2.08M

SUSQUEHANNA INTERNATIONAL GROUP, LLP

medicinal chemicals & botanical products

2.69M1.43%

1.43%

$3.93BNov 14, 2025 1.53M

JANE STREET GROUP, LLC

medicinal chemicals & botanical products

2.19M1.16%

1.16%

$3.19BNov 14, 2025 1.71M

SUSQUEHANNA INTERNATIONAL GROUP, LLP

medicinal chemicals & botanical products

1.97M1.04%

1.04%

$2.87BNov 14, 2025 1.43M

D. E. SHAW & CO., INC.

medicinal chemicals & botanical products

1.86M98.88%

98.88%

$2.72BNov 14, 2025 1.86M

CITADEL ADVISORS LLC

medicinal chemicals & botanical products

1.79M95.13%

95.13%

$2.62BNov 14, 2025 718.9K

MORGAN STANLEY

medicinal chemicals & botanical products

1.68M89.01%

89.01%

$2.45BMay 27, 2026 467.6K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

34

Increased

+19.46M shares

6

New Positions

first time holders

9

Decreased

−1.41M shares

0

Sold Out

fully exited

Net shares change (top 50)

+18.05M

+19.46M / −1.41M

Net new holders

+31

6 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

CGC insider trading · insider activity

Source: SEC Form 4

Buy 7%Active transactions only93% Sell

Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.

0

Buy transactions

5

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Yanofsky Theresa

director

Mar 31, 2026Sale10,373$0.93$9.6K53.1KForm 4 ↗

ATKINS M SHAN

director

Mar 31, 2026Sale2,074$0.93$1.9K41.4KForm 4 ↗

BAYERN JOSEPH

director

Mar 31, 2026Sale2,658$0.93$2.5K40.0KForm 4 ↗

Lazzarato David Angelo

director

Mar 31, 2026Sale15,624$0.93$14.5K72.0KForm 4 ↗

Mongeau Luc

Chief Executive Officer

Feb 11, 2026Sale9,376$1.06$10.0K803.0KForm 4 ↗

Yanofsky Theresa

director

Dec 31, 2025Sale10,434$1.13$11.8K63.5KForm 4 ↗

Lazzarato David Angelo

director

Dec 31, 2025Sale15,715$1.13$17.8K87.7KForm 4 ↗

BAYERN JOSEPH

director

Nov 11, 2025Award42,65842.7KForm 4 ↗

Lazzarato David Angelo

director

Sep 29, 2025Sale15,677$1.58$24.8K103.4KForm 4 ↗

ATKINS M SHAN

director

Sep 29, 2025Sale2,216$1.58$3.5K43.5KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Canopy Growth Corporation (CGC) is primarily owned by institutional investors, who hold approximately 7.5% of total shares outstanding. Company insiders own approximately 0.38%, while retail and public investors account for the remaining 92.07%.

The largest institutional shareholder of Canopy Growth Corporation is TOROSO INVESTMENTS, LLC, holding approximately 4.85 million shares — equal to 2.58% of outstanding shares — as of September 30, 2025.

A total of 232 institutional investors currently hold CGC stock, with a combined institutional value of approximately $46,952,416 as of the most recent 13F filing period.

Frequently asked questions

CGC ownership

Canopy Growth Corporation (CGC) is primarily owned by institutional investors, who hold approximately 7.5% of shares. The largest shareholder is TOROSO INVESTMENTS, LLC with a 2.58% stake. Company insiders hold 0.38%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns CGC stockCGC ownership structureSEC Form 13F institutional holdingsCGC float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025